Collegium Pharmaceutical, Inc. (COLL) Gross profit 2016–2025
Collegium Pharmaceutical, Inc. (COLL) annual gross profit history from SEC filings — each fiscal year as reported.
$463.3MFY2025 · since FY2016: $1.5M → $463.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $463.3M | +22.8% |
| FY2024 | $377.3M | +15.7% |
| FY2023 | $326.2M | +55.7% |
| FY2022 | $209.5M | +39.1% |
| FY2021 | $150.6M | -16.2% |
| FY2020 | $179.8M | +74.5% |
| FY2019 | $103.0M | -10.2% |
| FY2018 | $114.7M | +343.3% |
| FY2017 | $25.9M | +1627.7% |
| FY2016 | $1.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice